RXO - RXO, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$25.91
DETAILS
HIGH:
$35.00
LOW:
$18.00
MEDIAN:
$28.00
CONSENSUS:
$25.91
UPSIDE:
25.41%
AlphaVal
Deterministic, archetype-aware fair value
Cyclical & Capital-Intensive
80% confidence
Primary model: Normalized Earnings × Cycle Multiple
Adjust Assumptions
5.5x
0.23$
Key Value Driver
Through-cycle normalized EPS ($0.23)
Implied Market Multiple
91.1x
Plain-Language Summary
Using 7-year normalized EPS of $0.23 at a 6x cycle multiple, the base-case value is $1.25 per share.
Analyst Consensus (External Reference)
Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.
Average Target (21 analysts)
$25.91
Analyst Range
$18.00 – $35.00
Divergence from AlphaVal
95%
Warnings
This company has a built-in lending arm whose debt is mixed in with the main business. We capped the debt adjustment to avoid overstating what the core business owes.
Wall Street's average price target is $25.91 (from 21 analysts). Our estimate is 95% below the consensus -- consider that gap carefully.
Key Risks
- Standard 10-year DCF produces unreliable terminal values for cyclicals
- 'Cheap' P/E at cycle peak is the most common value trap — normalize first
- Captive finance subsidiaries have different risk profiles from manufacturing